Dr. Jennifer Walden: The Rare Female Plastic Surgeon

Dr. Jennifer Walden knows she is a rarity. She is a Texas-based plastic surgeon and a woman. In 2016, there were roughly 8,100 board-certified plastic surgeons in the United States. Of that number, only 851 were women. Walden likes her role, however. The statistics indicate that 92% of plastic surgery patients are women, which means Walden can identify and empathize with a lot of them. She is also proud of the fact that her staff consists of 16 women. “I have built my practice with an all-female team and my client base is mostly women,” she says.

Balancing work and family life can be a challenge for most women and Dr. Walden is no exception. She is a single mother raising twin boys, and she is fully aware that running a plastic surgery business and being a single parent is fraught with complications. To make things work, simplicity has become her goal.As a cosmetic plastic surgeon, she sets herself apart from other plastic surgeons with unique services. With 3D imaging technology, patients get to visualize what they would look like after augmentation surgeries. She uses SculpSure for laser fat reduction, the SmartGraft device for hair transplants, and the ThermiVa radiofrequency along with the diVa laser for vaginal rejuvenation.

Aside from the demands of plastic surgery, social engagements are high on her list. Dr. Walden serves on Austin’s Executive Leadership Team of the American Heart Association’s Go Red for Women campaign, she is a member of the Guardian Angel Society which helps and supports abused children, she supports the Junior League of Austin’s Food in Tummies program that provides food to elementary school children, and she helps fund teachers by sponsoring the Forest Trails Elementary School and the Eanes Education Foundation.Dr. Jennifer Walden was born and raised in Austin, Texas. She graduated with a bachelor’s in biology from the University of Austin. She later received her medical degree from the University of Texas Medical Branch at Galveston. Her residency in Integrated Plastic Surgery was completed there, too. In 2003, she was awarded an aesthetic surgery fellowship at the Manhattan Eye, Ear, and Throat Hospital.

Omar Boraie Pledges $1.5 Million Towards Genomic Science Chair Formed By Rutgers Cancer Institute Honoring Him

To promote precision medicine and accelerate research and development in the field of cancer research, a chair for Genome Science was recently established at Rutgers Cancer Institute. The chair was named after Omar Boraie, who is a serial entrepreneur and a legendary real estate developer based in New Brunswick. Omar Boraie has committed to making a donation of $1.5 Million reveals Bloomberg for the establishment of the Omar Boraie Chair, which is challenge initiative of the Rutgers University and a part of 18 Chair Challenge campaign. An anonymous donor has pledged to provide donation matching $1.5 Million for each chair, which raises the total endowment for each chair to $3 Million.

The world of medical science and cancer research has rapidly advanced in the last few years, and one of the branches that have shown some positive results is precision medicine and genome science. It helps the physicians and scientists to study the case of each patient on a genetic level, which helps in individualizing the treatment offered. The gene sequencing is done and practiced at many cancer centers across the globe, but Rutgers Cancer Institute was the first establishment in the country to collaborate genomic sequencing and the practice of precision medicine to offer an efficient treatment to the patients. In his state of Union Address, former U.S. President Obama announced last year how precision medicine could help in advancing cancer research initiatives. He also announced the launch of Precision Medicine program that would focus on finding a cure for cancer and better cancer therapies.

Sam Boraie for many decades has been a part of the development and success story of New Brunswick, and supporting this chair through his pledge is just another step towards helping the community on a broader scale. He has a background in chemistry and has for long been interested in the initiative for cancer research. He believes that the donation of his family and others in the 18 Chair would also help other affluent members of the society to come forward to support the cause. A news piece on the Omar Boraie’s contribution towards the formation of Chair is also published on NewsWise, a leading online news publication.

The chair has been assigned to the well-known Oncologist, Shridar Ganesan, MD, and Ph.D., who before joining Rutgers Cancer Institute was working with Dana-Farber Cancer Institute, which is a cancer research arm of Harvard Medical School. The formation of the chair would encourage the physicians and scientists working in the field of clinical research in precision medicine and cancer therapies.